Heart failure with preserved ejection fraction: updated diagnostic and therapeutic strategies. SEMI consensus document.

Heart failure (HF) is associated with high morbidity and mortality. HF with preserved left ventricular ejection fraction (HF-pEF) accounts for up to 50% of all HF cases, being the most common in elderly patients. In addition, these subjects frequently present other comorbidities. For all these reaso...

Descripción completa

Detalles Bibliográficos
Autores: Fernández Rodríguez, José María, Alonso Ortiz, M. B., Casado, Jesús, Chivite Guillén, David, Cubo Romano, Pilar, García Alonso, R., Lorenzo Almorós, Ana, Miramontes González, J.P., Soler Rangel, María Llanos, Pérez Silvestre, José
Tipo de recurso: artículo
Fecha de publicación:2026
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:inglés
OAI Identifier:oai:dnet:abacusreposi::4703a671dc77436c389aca455a3cde9e
Acceso en línea:https://hdl.handle.net/11268/16945
Access Level:acceso abierto
Palabra clave:Insuficiencia cardiaca
Inhibidores del Cotransportador de Sodio-Glucosa 2
Semaglutida
Enfermedad cardiovascular
Medicina preventiva
Investigación médica
Goal 3: Ensure healthy lives and promote well-being for all at all ages
Descripción
Sumario:Heart failure (HF) is associated with high morbidity and mortality. HF with preserved left ventricular ejection fraction (HF-pEF) accounts for up to 50% of all HF cases, being the most common in elderly patients. In addition, these subjects frequently present other comorbidities. For all these reasons, the diagnosis of patients with HF-pEF is complex and requires a careful approach. In addition, there are "secondary" or HF-pEF forms that must also be discarded. The treatment of HF-pEF has evolved very significantly in recent years due to evidence from clinical trials. All this makes it necessary to update the recommendations regarding the management of patients with HF-pEF.